• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
KDNY

KDNY

Chinook Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD40.39

+0.09 (+0.22%)

Company Profile

CEO

Eric L. Dobmeier

IPO Date

2020-10-06

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$40.31

Prev. Close

$40.30

Day Low

$40.30

Day High

$40.51

52W Low

$18.34

52W High

$40.51

Market Cap

$2.71B

Volume

3.28M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

20.5%

Avg Negative

2.5%

Avg Neutral

76.9%

News Feed

Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021

GlobeNewsWire·7/12/2021·↑ positive

Chinook Therapeutics Announces Promotions of Tom Frohlich to Chief Operating Officer and Andrew King, D.V.M, Ph.D., to Chief Scientific Officer

GlobeNewsWire·6/9/2021·↑ positive

Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data in Patients with IgA Nephropathy (IgAN) at the 58th ERA-EDTA Virtual Congress

GlobeNewsWire·6/8/2021·↑ positive

Chinook Therapeutics to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 58th ERA-EDTA Congress

GlobeNewsWire·5/25/2021·↑ positive

Chinook Therapeutics Presents Data During the ISN World Congress of Nephrology 2021

GlobeNewsWire·4/15/2021·↑ positive

Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewsWire·4/7/2021·↑ positive

Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases

GlobeNewsWire·4/7/2021·↑ positive

Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger

GlobeNewsWire·4/5/2021·↑ positive

Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewsWire·4/1/2021·↑ positive

Chinook (KDNY) Surges 7%: Is This an Indication of Further Gains?

Zacks Investment Research·3/31/2021·↑ positive